Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunoglobulin for Necrotizing Soft Tissue Infections: a Randomised Controlled Trial
2013-003556-20Phase 2Completed
- Sponsor
- Rigshospitalet
- Start
- Feb 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in necrotizing skin infection (NSTI) and necrotizing fasciitis (NF) comparing IVIg with Placebo (2 arms). Primary endpoint: Physical Component Summary Score (PCS) of Short Form-36 (SF-36). Started Feb 2014; status: completed.
02
Drugs
subcuvia
03
Conditions
necrotizing skin infection (NSTI)necrotizing fasciitis (NF)
Beyond the preview
Go deeper on 2013-003556-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-003556-20.